Aesthetic clinic advertising in Taiwan sits under the Taiwan Food and Drug Administration's (TFDA) restrictions on pharmaceutical and medical product advertising — including a ban on off-label promotion — alongside the Fair Trade Act's general prohibition on false or misleading advertising representations. Clinics making unsubstantiated outcome claims or naming prescription-only treatments outside their approved use are advertising in a way both regimes already restrict.
We build compliant campaigns from a real Taipei office, applying the same compliance-first discipline behind our Malaysia aesthetic clinic marketing work (KKM) to Taiwan's own regulatory frame.
What's different about advertising this in Taiwan
Aesthetic and cosmetic clinic advertising in Taiwan sits under the Taiwan Food and Drug Administration (TFDA)'s restrictions on pharmaceutical and medical product advertising, which prohibit off-label promotion — advertising a treatment for a use beyond its approved indication. The Fair Trade Act separately prohibits false or misleading representations about price, quality or treatment outcomes that could affect a trading decision, requiring credible evidence before a claim goes live. The Consumer Protection Act treats advertisement content as effectively part of the clinic's service warranty.
Self-check your own Taiwan clinic ad copy against these rules with our free TFDA Ad Compliance Checker, mirroring the same self-check approach as our Malaysia KKM checker and Hong Kong medical ad checker.